Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Released: July 25, 2002
Although dying is a part of life, a child's death, in a very real sense, is unnatural and has a devastating and enduring impact. Over 50,000 children die each year. This report builds on two earlier IOM reports - Approaching Death: Improving Care at the End of Life (1997) and Improving Palliative Care for Cancer (2001). It continues their arguments that medical and other support for people with fatal or potentially fatal conditions often falls short of what is reasonably if not simply attainable.
Released: July 24, 2002
Use of dietary supplements has increased significantly over the past decade. While these products are presumed safe when used by consumers, the U.S. Food and Drug Administration (FDA) has no authority to require specific safety studies be done prior to the products' appearance on the market. Current laws require that FDA prove a supplement is unsafe in order to remove it from the marketplace. At the request of FDA, Food and Nutrition Board committee has proposed a scientifically based approach to be used by FDA for prioritizing and evaluating dietary supplement ingredients on the basis of available information on safety.
Released: July 19, 2002
The workshop summary report explores the principles underlying the biological challenges, medical interventions, the continuing research agenda, and operational considerations for post-immunization strategies for vaccine-preventable viral diseases, and highlights important efforts that may facilitate wise decision making.
Released: July 15, 2002
This report focuses on the research environment and attempts to define and describe those elements that allow and encourage unique individuals, regardless of their role in the research organization or their backgrounds on entry, to act with integrity.
Released: July 06, 2002
Communication interventions intended to affect health behavior are an increasingly important strategy for improving the health of the American people. However, effective communication is highly dependent upon the social and cultural milieu that shapes the individuals, families, and communities that are the intended recipients. Because we live in an increasingly diverse nation, it is important to understand more fully how these different messages should be constructed and delivered. This report, Speaking of Health: Assessing Health Communication Strategies for Diverse Populations, addresses the challenge of improving health communications in a racially and culturally diverse society.
Released: June 25, 2002
Vulnerabilities abound in U.S. society. The openness and efficiency of our key infrastructures — transportation, information and telecommunications systems, health systems, the electric power grid, emergency response units, food and water supplies, and others — make them susceptible to terrorist attacks. Making the Nation Safer discusses technical approaches to mitigating these vulnerabilities.
Released: June 17, 2002
Every year approximately 30,000 people die by suicide in the United States, and one million worldwide. Over the last 100 years, suicides have out-numbered homicides by at least 3 to 2. Concerned about high suicide rates, several federal agencies joined together to ask the Institute of Medicine to convene the Committee on Pathophysiology and Prevention of Adolescent and Adult Suicide to examine the state of the science base, gaps in our knowledge, strategies for prevention, and research designs for the study of suicide. The committee's report, Reducing Suicide: A National Imperative, explores what is known about the epidemiology, risk factors, and interventions for suicide and suicide attempts.
Released: June 12, 2002
This workshop summary report, The Role of Purchasers and Payers in the Clinical Research Enterprise, documents and summarizes what employers and insurers need from and are willing to contribute to clinical research from both a business and a national health care perspective.
Released: June 10, 2002
This report looked at the possibility that the scientific method could be accelerated to yield findings more quickly by identifying patterns of evolving evidence in nutrient-disease relationships.
Released: May 30, 2002
In the report, Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders, the Institute of Medicine (IOM) Immunization Safety Review Committee reviewed the evidence regarding the hypothesis that the hepatitis B vaccine causes demyelinating disorders.